Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

GPCR Target: LPA5

Authors: Zhang D, et al.

Journal: Eur J Med Chem. 2022 Dec 5;243:114741. doi: 10.1016/j.ejmech.2022.114741

Year Published: 2022

Leave a Reply